Dennis Kim

Chief Medical Officer

Dr. Kim joined CymaBay in May 2021 as our Chief Medical Officer. He brings more than 20 years of drug development experience most recently serving as Chief Medical Officer of Afyx Therapeutics, where he led clinical, medical and regulatory development for Rivelin, a novel mucoadhesive patch to deliver treatment for diseases such as oral lichen p...

Roles at Cymabay Therapeutics

  • Chief Medical Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.